Summit Therapeutics (SMMT) had the highest return between September 1, 2022 and December 11, 2022 by a large-cap US stock, returning 224%.
| ASSET | DATE | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | 9/1/2022 - 12/11/2022 | 223.97% |
Roivant Sciences (ROIV) | 9/1/2022 - 12/11/2022 | 93.37% |
IAMGold (IAG) | 9/1/2022 - 12/11/2022 | 71.43% |
Tencent Music Entertainment (TME) | 9/1/2022 - 12/11/2022 | 63.54% |
Eldorado Gold (EGO) | 9/1/2022 - 12/11/2022 | 50.83% |
Nutanix (NTNX) | 9/1/2022 - 12/11/2022 | 49.21% |
Rambus (RMBS) | 9/1/2022 - 12/11/2022 | 47.59% |
Biogen (BIIB) | 9/1/2022 - 12/11/2022 | 46.52% |
Axon Enterprise (AXON) | 9/1/2022 - 12/11/2022 | 46.45% |
Hecla Mining (HL) | 9/1/2022 - 12/11/2022 | 45.4% |
Netflix (NFLX) | 9/1/2022 - 12/11/2022 | 44.98% |
DexCom (DXCM) | 9/1/2022 - 12/11/2022 | 42.56% |
AngloGold Ashanti (AU) | 9/1/2022 - 12/11/2022 | 41.72% |
Medpace (MEDP) | 9/1/2022 - 12/11/2022 | 41.37% |
Gold Fields Ltd ADR (GFI) | 9/1/2022 - 12/11/2022 | 41.1% |
Halozyme Therapeutics (HALO) | 9/1/2022 - 12/11/2022 | 40.71% |
Gilead Sciences (GILD) | 9/1/2022 - 12/11/2022 | 40.31% |
Royal Caribbean Cruises (RCL) | 9/1/2022 - 12/11/2022 | 40.17% |
Burlington Stores (BURL) | 9/1/2022 - 12/11/2022 | 39.64% |
Alamos Gold (AGI) | 9/1/2022 - 12/11/2022 | 39.6% |
Vale SA ADR (VALE) | 9/1/2022 - 12/11/2022 | 39.08% |
TechnipFMC (FTI) | 9/1/2022 - 12/11/2022 | 38.68% |
Renaissancere (RNR) | 9/1/2022 - 12/11/2022 | 38.43% |
Fair Isaac (FICO) | 9/1/2022 - 12/11/2022 | 38.3% |
Futu (FUTU) | 9/1/2022 - 12/11/2022 | 38.29% |
Large-cap stocks are treated as having a market cap of $10B+.